We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
On Friday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $84.95 which represents a slight increase of $0.28 or 0.33% from the prior close of $84.67. The stock opened at $84 ...
Gilead Sciences said on Thursday it would donate about 5,000 vials of its antiviral drug remdesivir to the Rwanda Medical ...
GlobalData on MSN13d
Gilead signs agreements to facilitate access to HIV prevention drugGilead Sciences has announced the signing of voluntary licencing agreements with six generic pharmaceutical manufacturers to ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of new findings from its antiviral research ...
The U.S.-based drugmaker also plans to provide the companies branded version of the drug, lenacapavir, in 18 countries, such ...
6d
Future Financial Wealth Managment LLC acquired a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in ...
Application error: a client-side exception has occurred (see the browser console for more information).
Gilead Sciences Inc. has announced a new licensing deal to provide its twice-yearly experimental HIV prevention drug, lenacapavir, to six ...
Ferozsons Laboratories Limited (PSX: FEROZ) has entered into a non-exclusive voluntary license agreement with Gilead Sciences ...
(Reuters) -Gilead Sciences said on Thursday it would donate ... before spreading through contact with the bodily fluids of those infected. (Reporting by Mariam Sunny in Bengaluru; Editing by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback